`To:
`Cc:
`Subject:
`Date:
`
`PTABE2E_System@uspto.gov
`*dueppen-ptab; joelke@fenwick.com; ryan.johnson@fenwick.com; *White-ptab
`*Greb-ptab; laura.moran@fenwick.com
`IPR2020-00324: Document(s) Filed - Mylan Institutional LLC v. Novo Nordisk A/S
`Friday, March 05, 2021 5:49:19 PM
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`PATENT TRIAL AND APPEAL BOARD
`
`Document Filing Notice
`
`AIA Review No.: IPR2020-00324
`Petitioner:
`Mylan Institutional LLC et al. of Canonsburg, PA
`Patent Owner:
`Novo Nordisk A/S et al.
`Patent No.:
`8114833
`Submitted Date: 03/05/2021
`Submitted By:
`Lara Dueppen, dueppen-ptab@perkinscoie.com
`
`The following document(s) has/have been filed.
`
`Document(s) List
`
`No. Document
`No.
`
`Document
`Type
`
`Document Name
`
`1
`
`54
`
`Motion
`
`Petitioners Motion to Exclude
`Evidence (CONFIDENTIAL)
`
`Filing
`Party
`
`Petitioner
`
`Availability
`
`Available
`only to
`board.
`
`Questions regarding this receipt should be directed to the Patent Trial and Appeal Board at
`571-272-7822 or e-mail to Trials@uspto.gov.
`
`This e-mail is computer-generated. Do not reply to this e-mail because the e-mail box is not
`monitored.
`
`MYLAN INST. EXHIBIT 1132 PAGE 1
`
`MYLAN INST. EXHIBIT 1132 PAGE 1
`
`